Skip to the page

Data / Form D filings / Pathos AI, Inc.

Pathos AI, Inc.: Form D filings

Pathos AI, Inc., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on May 1, 2025, reports $283 million sold of a $400 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
600 W. CHICAGO AVE., SUITE 510, Chicago, IL, 60654
Phone
(312) 765-7820
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1967854

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 1, 2025New notice$399,999,933$282,999,950$116,999,98311Apr 17, 2025sec.gov
Nov 6, 2024New notice$61,999,979$61,999,97913Oct 24, 2024sec.gov
Mar 2, 2023New notice$39,999,988$19,999,992$19,999,9964Feb 17, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan FukushimaExecutive Officer, Director
Mohamad MakhzoumiDirector
Alex DolanExecutive Officer
Andrew HeinleinExecutive Officer
Tyrell RiversDirector
Amit MehtaDirector
Eric LefkofkyExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Apr 28, 2025 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Pathos AI, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.